Autopsy report · NCT00576160

Improving Medication Adherence in Post-ACS Patients

“This was a dosing study to determine acceptability. Participants found protocol burdensome and so we terminated.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months after it had already started.
• Ran for about 3 years 10 months before it stopped.
• 22 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Columbia University

Sponsor type

University, hospital or other

Conditions

Medication Adherence; Acute Coronary Syndrome

Interventions

PST therapy

Participants

22

Sites

1

Countries

United States

Trials that died the same way

• Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
  “The study was terminated due to excessive toxicity and low compliance to the protocol scheme.” (77% match in meaning)
• Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer
  “This study has been terminated due to meeting protocol defined futility.” (69% match in meaning)
• Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery
  “The study was terminated on the basis that protocol defined stopping criteria had been met.” (67% match in meaning)
• Saracatinib in Treating Patients With Prostate Cancer
  “Per protocol, study was terminated due to low rate of randomized patients.” (65% match in meaning)
• A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Hematologic Malignancies (MK-8628-005)
  “This study was terminated due to limited efficacy and not due to safety reasons” (65% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.